Stephen C. BurgessA cancer diagnosis changes everything. Between treatment decisions, medical appointments, and the emotional toll on you and your family, the last thing you should have to worry about is whether your insurance company will honor your critical illness policy.
But filing a cancer-related critical illness claim correctly matters — because insurers evaluate these claims against very specific policy definitions that may not match your understanding of what "cancer" means.
How Critical Illness Policies Define Cancer
This is where many policyholders are caught off guard. Most critical illness policies cover cancer, but the policy definition often excludes certain types. A typical policy definition might read something like:
"A malignant tumor characterized by the uncontrolled growth and spread of malignant cells with invasion of tissue."
That sounds straightforward — until you see the exclusions. Most policies exclude:
- Carcinoma in situ (cancer that has not invaded surrounding tissue)
- Pre-malignant conditions such as dysplasia or cervical intraepithelial neoplasia
- Non-melanoma skin cancers (basal cell carcinoma and squamous cell carcinoma)
- Early-stage prostate cancer below a specified Gleason score (commonly 7 or higher required)
- Early-stage thyroid cancer (papillary microcarcinoma under a certain size)
A clinical cancer diagnosis does not automatically mean your critical illness policy will pay. The policy definition is what controls — and it is often narrower than the medical definition. Always check your specific policy language before filing.
Documentation You Will Need
Cancer claims require thorough medical documentation that clearly establishes the type, stage, and characteristics of the cancer. At a minimum, gather:
- Pathology report — This is the most critical document. It confirms the type of cancer, whether it is invasive, and the specific characteristics (grade, margins, receptor status for breast cancer, Gleason score for prostate cancer, etc.)
- Imaging results — CT scans, MRIs, PET scans, or other imaging that shows the extent of the disease
- Oncologist's narrative — A letter from your treating oncologist describing the diagnosis, staging, and treatment plan
- Surgical reports if a biopsy or tumor removal was performed
- Lab work including tumor markers or genetic testing results where relevant
The pathology report is the single most important document in a cancer critical illness claim. If it clearly shows invasive malignancy, the rest of the claim is largely a matter of paperwork. If the pathology is ambiguous, that is where disputes arise.
Common Reasons Cancer Claims Are Denied
Having worked hundreds of cancer-related critical illness claims, I see the same denial patterns repeatedly:
The "Not Invasive" Denial
The insurer determines that the cancer is in situ rather than invasive. This is the most common denial reason for cancer claims. Carcinoma in situ is excluded from most critical illness policies because the cancer has not yet spread beyond its original site.
If you receive this denial, have your oncologist review the policy definition and provide a detailed letter explaining why your specific cancer meets the invasive criteria, supported by pathology findings.
The Exclusion for Early-Stage Cancer
Some policies exclude early-stage cancers that have a high cure rate and minimal impact on life expectancy. Prostate cancer below a certain Gleason score and thyroid microcarcinomas are the most common examples.
These exclusions exist because critical illness policies are designed to cover severe, life-altering diagnoses. Insurers argue that certain early-stage cancers do not meet that threshold.
If your cancer was initially staged as early-stage but has since progressed, updated pathology and imaging showing progression may support a new claim or appeal. Cancer staging can change as more information becomes available.
The Contestability Investigation
If your policy is less than two years old, the insurer has the right to investigate your application for material misrepresentations. In cancer claims, they often look for evidence that you had symptoms, screening results, or prior diagnoses that you did not disclose on your application.
This does not mean your claim is invalid — but it does mean the insurer may delay the decision while they investigate your medical history.
Filing Tips for Cancer Claims
Based on what I have seen work best:
- File early. Do not wait for treatment to conclude. Most policies pay on diagnosis, not on treatment outcome.
- Lead with the pathology report. Make sure it is complete and clearly shows the type and invasiveness of the cancer.
- Match your documentation to the policy definition. If the policy requires "invasion of tissue," make sure your physician's letter uses that specific language.
- Anticipate exclusions. If your cancer is near a policy exclusion boundary (borderline Gleason score, question of in situ vs. invasive), address this proactively in your claim submission rather than waiting for the insurer to raise it.
Ask your oncologist to review your policy's cancer definition before writing their supporting letter. Physicians who understand what the insurer is looking for can provide documentation that directly addresses the policy criteria, which significantly strengthens your claim.
When a Cancer Claim Is Denied
If your cancer claim is denied, do not accept the decision without an independent review. Cancer claim denials are among the most commonly overturned on appeal, particularly when the denial was based on a narrow reading of the policy definition.
An experienced claim advocate can review your pathology, compare it to the policy language, and determine whether the denial is justified. In many cases, additional medical evidence or a specialist opinion is all it takes to reverse the decision.
You are dealing with enough. Your insurance company should be part of the solution, not another obstacle. If they are not honoring their commitment, you have the right to fight for the benefit you were promised.